3
Registered trials
0
Recruiting
3
Unique sponsors
3
Unique IMPs
1
Commercial trials
Drug classes (ATC)
N
Neurology/Psychiatry (ATC N)
1
—
ATC code not specified
2
Mechanism of action (INN-stem analysis)
Unknown / small molecule
3 substances
Phase III:
1
Phase II:
2
Phase III
1 trial-
EndedCentre Hospitalier Universitaire De Saint Etienne Academic3-AMINO-4-[2-[[METHYL((111C)METHYL)AMINO]METHYL]PHENYL]SULFANYLBENZONITRILE
Phase II
2 trials-
PendingOrexa B.V. CommercialLIDOCAINE HYDROCHLORIDE MONOHYDRATE
-
PendingRegion Skane AcademicDRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Orexa B.V. | Commercial | 1 | Phase II | 0 |
| Region Skane | Academic | 1 | Phase II | 0 |
| Centre Hospitalier Universitaire De Saint Etienne | Academic | 1 | Phase III | 0 |